Dr. Zoi Piperigkou

Zoi Piperigkou received her Ph.D. in Biochemistry, Cellular and Molecular Biology at the University of Patras (Greece) in 2018, where she evaluated the role of estrogen receptor beta in the modulation of matrix biomolecules expression, functional properties, morphological characteristics and epigenetic regulation, focusing on the miRNAs of aggressive breast cancer cells. She then began a postdoctoral fellowship at the University of Patras to focus on the role of biomimetic extracellular matrix scaffolds in provoking stem cell chondrogenic differentiation, with the aim of the design and development of a personalized therapy for osteoarthritis. In recent years, her research interests have focused on extracellular matrix, proteoglycans, glycosaminoglycans, epigenetics, and cancer cell pathobiology. She has participated in National and European projects (Marie Skłodowska-Curie action- Horizon 2020, 2016-2018) and in competitive European Projects in collaboration with Foundation for Research and Technology-Hellas (FORTH)/Institute of Chemical Engineering Sciences (ICE-HT). She is the co-author of 32 publications in peer-reviewed international scientific journals (h-index:18; i10-index:25).